Biopharma M&A
Recent deal announcements covering the last 60 days. Deal activity continues to be strong, led by Pfizer’s winning $14 billion bid for Medivation over the likes of [...]
Nivolumad Therapy in Kidney Cancer
The use of nivolumab improved 4- and 5-year overall survival three-fold in patients with kidney cancer, according to data presented at the ASCO Annual Meeting. This is [...]
FDA Final Guidance – General Wellness Devices
Here is a brief summary of the FDA guidance document (which is only 13 pages) for general wellness devices that was released July 29. Good news for [...]